Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

Atellica CH Revised C Reactive Protein (RCRP) Recalled by Siemens Healthcare Diagnostics, Inc. Due to Incorrect software flagging may occur for the assay...

Date: March 11, 2025
Company: Siemens Healthcare Diagnostics, Inc.
Status: Ongoing
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Siemens Healthcare Diagnostics, Inc. directly.

Affected Products

Atellica CH Revised C Reactive Protein (RCRP); Siemens Material Number (SMN): 11537223.

Quantity: N/A

Why Was This Recalled?

Incorrect software flagging may occur for the assay that may potentially lead to an erroneous result.

Where Was This Sold?

This product was distributed nationwide across all 50 states.

Affected (51 states)Not affected

About Siemens Healthcare Diagnostics, Inc.

Siemens Healthcare Diagnostics, Inc. has 452 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report